Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.440
+0.010 (0.70%)
Feb 21, 2025, 4:00 PM EST - Market closed
SONN Market Cap
SONN has a market cap or net worth of $4.41 million as of February 21, 2025. Its market cap has increased by 2.73% in one year.
Market Cap
4.41M
Enterprise Value
-335.94K
1-Year Change
2.73%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since April 2, 2020, SONN's market cap has decreased from $58.10M to $4.41M, a decrease of -92.40%. That is a compound annual growth rate of -40.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 4.41M | 0.54% |
| Dec 31, 2024 | 4.39M | -17.79% |
| Dec 29, 2023 | 5.34M | -41.46% |
| Dec 30, 2022 | 9.12M | -63.34% |
| Dec 31, 2021 | 24.89M | -35.01% |
| Dec 31, 2020 | 38.30M | -34.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |